Literature DB >> 11588525

Increased contribution of L-arginine-nitric oxide pathway in aorta of mice lacking the gene for vimentin.

J Zhang1, D Henrion, T Ebrahimian, J Benessiano, E Colucci-Guyon, F Langa, B I Lévy, C M Boulanger.   

Abstract

Experiments were designed to investigate endothelial function in the aorta of mice lacking the gene for the cytoskeleton protein vimentin (vim -/- ). Rings with and without endothelium from wild-type (vim +/+ ), heterozygous (vim +/- ), and homozygous (vim -/- ) mice were suspended in organ chambers to record of changes in isometric tension. During phenylephrine contraction, acetylcholine evoked comparable endothelium-dependent relaxations in the three groups. In the presence of Nomega-nitro-L-arginine, acetylcholine caused endothelium-dependent contractions, which were greater in vim -/- than in vim +/+ and vim +/- aortas. Indomethacin did not affect relaxation to acetylcholine in vim +/+ or in vim +/-, but it significantly increased the maximal response in vim -/- (67 +/- 7 vs. 102 +/- 4%). Response to acetylcholine in vim -/- aortas was not affected by cyclooxygenase type 2 inhibitor NS-398, the thromboxane receptor antagonist SQ-29,548, or superoxide dismutase. Relaxations to sodium nitroprusside were not different between vim +/+ and vim -/- mice and were not affected by cyclooxygenase inhibition. Cyclic guanosine monophosphate levels, which were increased to a comparable level by acetylcholine in vim +/+ and vim -/-, were augmented by indomethacin in vim -/- aortas but not in vim +/+ aortas. Expression of endothelial nitric oxide synthase was not different between vim +/+ and vim -/- preparations. These results suggest that despite comparable endothelium-dependent responses to acetylcholine, endothelial cells from vim -/- mice release a cyclooxygenase product that compensates the augmented contribution of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588525     DOI: 10.1097/00005344-200110000-00007

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  2 in total

1.  Vimentin Suppresses Inflammation and Tumorigenesis in the Mouse Intestine.

Authors:  Linglu Wang; Ponnuswamy Mohanasundaram; Michelle Lindström; Muhammad Nadeem Asghar; Giulia Sultana; Julia O Misiorek; Yaming Jiu; Hongbo Chen; Zhi Chen; Diana M Toivola; Fang Cheng; John E Eriksson
Journal:  Front Cell Dev Biol       Date:  2022-03-25

2.  Murine colitis is mediated by vimentin.

Authors:  Nirit Mor-Vaknin; Maureen Legendre; Yue Yu; Carlos H C Serezani; Sanjay K Garg; Anna Jatzek; Michael D Swanson; Marta J Gonzalez-Hernandez; Seagal Teitz-Tennenbaum; Antonello Punturieri; N Cary Engleberg; Ruma Banerjee; Marc Peters-Golden; John Y Kao; David M Markovitz
Journal:  Sci Rep       Date:  2013-01-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.